COMMUNIQUÉS West-GlobeNewswire
-
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026 -
ASAP Dental Care Sets New Benchmark in Clinical Excellence with Over 229,000 Successful Procedures Performed
28/04/2026 -
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026
28/04/2026 -
Glass House Brands Announces Warrant Redemption Notice
28/04/2026 -
Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026
28/04/2026 -
Financial and Strategic Review, Annual General Meeting, and Trading Halt
28/04/2026 -
Corza Medical Reaffirms Commitment to Gut Sutures Amid Changing Market Landscape
28/04/2026 -
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
28/04/2026 -
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026 -
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
28/04/2026 -
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
28/04/2026 -
Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12
28/04/2026 -
Disclosure of transparency notification from BlackRock, Inc.
28/04/2026 -
FDA Announces Major Steps to Implement Real-Time Clinical Trials
28/04/2026 -
Chaque minute compte : l’EAACI appelle à une action urgente pour garantir à l’école la sécurité des enfants exposés au risque d’anaphylaxie
28/04/2026 -
EssilorLuxottica: Assemblée générale 2026 d’EssilorLuxottica
28/04/2026 -
EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders’ Meeting
28/04/2026 -
CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
28/04/2026 -
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies
28/04/2026
Pages